Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting.
Viktoria MusterMarkus WallnerAlbrecht SchmidtMartin KaplFriederike von LewinskiPeter RainerPia ReittnerManfred TillichPeter BraderDieter Hm SzolarDirk von LewinskiPublished in: The Journal of international medical research (2018)
Objective This study was performed to determine whether add-on oral ivabradine in patients treated with beta blockers 1 hour before coronary computed tomographic angiography (CCTA) is effective in lowering the heart rate and thus improving CCTA quality. Methods In this single-center cohort study, the data of 294 patients referred for ambulant CCTA were retrospectively screened. Patients with an initial heart rate of ≥75 bpm (n = 112) were pretreated with either a combination of bisoprolol and ivabradine or with bisoprolol alone. Results During the scan, there was no difference in heart rate between the two groups Likewise, there was no significant difference in additionally administered intravenous bradycardic agents, the number of motion artifacts, or the radiation dose. Both drug regimens were tolerated well. Conclusion Additive oral ivabradine 1 hour before CCTA does not result in a further reduction of the heart rate. Consequently, neither movement artifacts nor radiation dose can be reduced. Therefore, pretreatment with ivabradine does not seem reasonably appropriate in an outpatient clinical setting with short patient contact.
Keyphrases
- heart rate
- blood pressure
- heart rate variability
- computed tomography
- optical coherence tomography
- coronary artery disease
- coronary artery
- ejection fraction
- end stage renal disease
- newly diagnosed
- magnetic resonance imaging
- emergency department
- machine learning
- image quality
- electronic health record
- high dose
- deep learning
- big data
- mass spectrometry
- quality improvement
- bone marrow
- cell therapy
- peritoneal dialysis
- artificial intelligence
- drug induced